Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

122.26 +0.40 (+0.33%)
Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
News headline image
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever ↗
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake. 
Via The Motley Fool
Topics Stocks
News headline image
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk ↗
Via The Motley Fool
News headline image
Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs ↗
President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs. 
Via Benzinga
Topics Government
News headline image
Is Merck Stock a Buy? ↗
Via The Motley Fool
News headline image
2 Healthcare Stocks with Big Upside and 1 to Skip
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
News headline image
Looking Into Merck & Co's Recent Short Interest ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 13 Analysts Discuss Merck & Co Stock ↗
 
Via Benzinga
News headline image
Eli Lilly Remains JPMorgan's Top Biopharma Pick For 2025, But Gilead And Bristol Myers Also Gain Praise — Is Retail On Board? ↗
JPMorgan sees Gilead well-positioned due to its strong HIV drug portfolio and disciplined expense management. 
Via Stocktwits
News headline image
Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks
Check out these three mega-cap names, valued over $200 billion each, that just authorized a combined $28 billion in buybacks. 
Via MarketBeat
Topics Earnings Economy Intellectual Property
News headline image
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail Buzz Intensifies ↗
The company said that Merck’s TICE BCG shortages have created a significant hurdle for bladder cancer treatment. 
Via Stocktwits
News headline image
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports ↗
Trump's proposed 25% tariffs on auto, semiconductor, and pharmaceutical imports have rattled markets and could affect ETFs with heavy exposure to these sectors. 
Via Benzinga
Topics ETFs Government World Trade
News headline image
Why NYSE:MRK is a Top Pick for Dividend Investors. ↗
Why MERCK & CO. INC. (NYSE:MRK) provides a good dividend, while having solid fundamentals. 
Via Chartmill
News headline image
Decoding Merck & Co's Options Activity: What's the Big Picture? ↗
 
Via Benzinga
News headline image
Europe Approves Merck's Cancer Drug For Two Indications ↗
Merck's Welireg receives conditional EU approval for VHL disease-associated tumors and advanced RCC, expanding its global presence across 30+ countries. 
Via Benzinga
News headline image
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich ↗
Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion. 
Via Benzinga
Topics Government
News headline image
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock ↗
 
Via Benzinga
News headline image
Market Whales and Their Recent Bets on MRK Options ↗
 
Via Benzinga
News headline image
MarketBeat Week in Review – 02/10 - 02/14
Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in 
Via MarketBeat
Topics Credit Cards Economy Government
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
In a market where value is scarce, NYSE:MRK offers a refreshing opportunity with its solid fundamentals. ↗
MERCK & CO. INC. has caught the attention as a great value stock. NYSE:MRK excels in profitability, solvency, and liquidity, all while being very reasonably priced. 
Via Chartmill
News headline image
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch ↗
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
Topics Government
News headline image
3 Blue-Chip Dividend Stocks Trading at Multiyear Lows ↗
Via The Motley Fool
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗
Via The Motley Fool
News headline image
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes ↗
This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments. 
Via Stocktwits
News headline image
Gilead Sciences Beats Q4 EPS Forecast ↗
Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments. 
Via The Motley Fool
News headline image
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong ↗
The HPV vaccine had been a key growth driver in China until last year when economic headwinds disrupted demand. 
Via Stocktwits
News headline image
Merck: 4 No-Brainer Reasons to Buy This Dip
Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity. 
Via MarketBeat
News headline image
Better High-Yield Dividend Stock: Pfizer vs. Merck ↗
Via The Motley Fool
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.